---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-24-000091"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:26:54.575342+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience stockholders approve amended omnibus incentive plan, increasing share pool by 1.54M

## Summary
- Stockholders voted 17.4M for, 6.2M against to approve the Amended and Restated Omnibus Incentive Plan.
- Plan increases authorized shares by 1,535,655 and raises incentive stock option limit to 4,000,000.
- Plan expiration extended to September 10, 2034; automatic share replenishment feature retained.
- Approval became effective upon stockholder vote at Special Meeting on October 22, 2024.

## SEC filing metadata
- accession: 0001516551-24-000091
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/0001516551-24-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/skye-20241022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-24-000091
- JSON: https://secwatch.observer/filing/0001516551-24-000091.json
- Plain text: https://secwatch.observer/filing/0001516551-24-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.